Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 3:45 PM UTC
| NCT Number | NCT07415031 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE2 |
| Target Enrollment | 170 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Mirati Therapeutics Inc. |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 29, 2026: Clinical trial NCT07415031 is currently recruiting participants. This phase2 study for solid tumors is actively seeking new participants at 17 locations across the United States. The study is sponsored by Mirati Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07415031 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07415031 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.